Derbalah Abdallah, Abdulla Tariq, De Sousa Mendes Mailys, Wu Qier, Stader Felix, Jamei Masoud, Gardner Iain, Sepp Armin
Certara Predictive Technologies Division, Certara UK Ltd., Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, UK.
Pharmaceutics. 2025 May 2;17(5):604. doi: 10.3390/pharmaceutics17050604.
Physiologically based pharmacokinetic (PBPK) modelling for biologics, such as monoclonal antibodies and therapeutic proteins, involves capturing complex processes, including target-mediated drug disposition (TMDD), FcRn-mediated recycling, and tissue-specific distribution. The Simcyp Designer Biologics PBPK Platform Model offers an intuitive and efficient platform for constructing mechanistic PBPK models with pre-defined templates and automated model assembly, reducing manual input and improving reproducibility. This tutorial provides a step-by-step guide to using the platform, highlighting features such as cross-species scaling, population variability simulations, and flexibility for model customization. Practical case studies demonstrate the platform's capability to streamline workflows, enabling rapid, mechanistic model development to address key questions in biologics drug development. By automating critical processes, this tool enhances decision-making in translational research, optimizing the modelling and simulation of large molecules across discovery and clinical stages.
用于生物制品(如单克隆抗体和治疗性蛋白质)的基于生理的药代动力学(PBPK)建模涉及捕捉复杂过程,包括靶点介导的药物处置(TMDD)、FcRn介导的再循环以及组织特异性分布。Simcyp Designer Biologics PBPK平台模型提供了一个直观且高效的平台,用于使用预定义模板和自动模型组装构建机制性PBPK模型,减少人工输入并提高可重复性。本教程提供了使用该平台的分步指南,突出了跨物种缩放、群体变异性模拟以及模型定制灵活性等功能。实际案例研究展示了该平台简化工作流程的能力,能够实现快速、机制性的模型开发,以解决生物制品药物开发中的关键问题。通过自动化关键过程,该工具增强了转化研究中的决策制定,优化了跨发现和临床阶段的大分子建模与模拟。